You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0441 Risk-Benefit of Co-Administered Traumeel® (TR14) and Zeel® (ZE14) Intra-Articular (IA) Injections in Patients with Moderate-to-Severe Pain Associated with OA of the Knee (OAK)

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Osteoarthritis
THU0441 Risk-Benefit of Co-Administered Traumeel® (TR14) and Zeel® (ZE14) Intra-Articular (IA) Injections in Patients with Moderate-to-Severe Pain Associated with OA of the Knee (OAK)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lozada C, del Rio E, Reitberg D, et al
THU0441 Risk-Benefit of Co-Administered Traumeel® (TR14) and Zeel® (ZE14) Intra-Articular (IA) Injections in Patients with Moderate-to-Severe Pain Associated with OA of the Knee (OAK)
Annals of the Rheumatic Diseases 2015;74:359.